Cargando…

A Big Problem and Debate in COVID-19 Pandemics: Equitable and Effective Access of the COVID-19 Vaccines and Waiver of Intellectual Property

Detalles Bibliográficos
Autor principal:	Kasapçopur, Özgür
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Turkish Pediatrics Association 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655952/ https://www.ncbi.nlm.nih.gov/pubmed/35005720 http://dx.doi.org/10.5152/TurkArchPediatr.2021.180621

Ejemplares similares

Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma
por: Okereke, M., et al.
Publicado: (2021)

Mixed response to COVID-19 intellectual property waiver
por: Zarocostas, John
Publicado: (2022)

What next for a COVID-19 intellectual property waiver?
por: Zarocostas, John
Publicado: (2021)

Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem
por: Barnes-Weise, Julia, et al.
Publicado: (2022)

US Support for a WTO Waiver of COVID-19 Intellectual Property
por: Contreras, Jorge L.
Publicado: (2021)

Ensuring fair distribution of COVID-19 vaccines: is an intellectual waiver the answer?
por: Burki, Talha Khan
Publicado: (2021)

A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness
por: Amin, Tahir, et al.
Publicado: (2022)

Ensuring equitable access to COVID-19 vaccines
Publicado: (2020)

COVAX and equitable access to COVID-19 vaccines
por: Yoo, Katelyn J, et al.
Publicado: (2022)

COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic
por: Sharun, Khan, et al.
Publicado: (2021)

The Race for Global Equitable Access to COVID-19 Vaccines
por: Md Khairi, Lukman Nul Hakim, et al.
Publicado: (2022)

Science and pseudoscience during the COVID-19 pandemic
por: Kasapçopur, Özgür
Publicado: (2020)

Get waivered remote: Nationwide, remote DEA-x waiver course in response to COVID-19
por: Martin, Alister, et al.
Publicado: (2021)

Access to and equitable distribution of COVID-19 vaccine in low-income countries
por: Acharya, Krishna Prasad, et al.
Publicado: (2021)

Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines
por: Manriquez Roa, Tania, et al.
Publicado: (2021)

Challenges in the equitable access to COVID-19 vaccines for migrant populations in Europe
por: Armocida, Benedetta, et al.
Publicado: (2021)

Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines
por: Bell, Eleanor, et al.
Publicado: (2022)

Equitable Access to Telehealth and Other Services for Deaf People During the COVID-19 Pandemic
por: Moreland, Christopher J., et al.
Publicado: (2023)

The IP Waiver for COVID-19: Bad Policy, Bad Precedent
por: Mercurio, Bryan
Publicado: (2021)

Breathing fresh air into the debate: Ventilators and the United States' intellectual property problem
por: Tiffney, Theora W., et al.
Publicado: (2022)

Equitable distribution of COVID-19 vaccines
por: Burki, Talha
Publicado: (2021)

Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access
por: Phelan, Alexandra L, et al.
Publicado: (2020)

Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines?
por: Okereke, Melody
Publicado: (2021)

Why the COVID-19 pandemic should be a call for action to advance equitable access to medicines
por: Kohler, Jillian C., et al.
Publicado: (2020)

A pandemic treaty for equitable global access to medical countermeasures: seven recommendations for sharing intellectual property, know-how and technology
por: Perehudoff, Katrina, et al.
Publicado: (2022)

Implementation of Federal Waivers for Feeding Children in Early Care and Education During the COVID-19 Pandemic
por: Dev, Dipti A., et al.
Publicado: (2022)

Emotion and COVID-19: Toward an Equitable Pandemic Response
por: Allen, Bennett
Publicado: (2021)

Recommendations for equitable COVID-19 pandemic recovery in Canada
por: Persaud, Nav, et al.
Publicado: (2021)

HPR63 Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines
por: Bell, E, et al.
Publicado: (2022)

Migrant health is public health: a call for equitable access to COVID-19 vaccines
por: Al-Oraibi, Amani, et al.
Publicado: (2021)

The Effect of Supervision Waivers on Practice: A Survey of Massachusetts Nurse Practitioners During the COVID-19 Pandemic
por: O’Reilly-Jacob, Monica, et al.
Publicado: (2021)

The Waiver of Patent Protections for COVID-19 Vaccines During the Ongoing Pandemic and the Conspiracy Theories: Lights and Shadows of an Issue on the Ground
por: Nioi, Matteo, et al.
Publicado: (2021)

COVID-19: Need for Equitable and Inclusive Pandemic Response Framework
por: Mustafa, Sabeena, et al.
Publicado: (2020)

International Collaboration to Ensure Equitable Access to Vaccines for COVID‐19: The ACT‐Accelerator and the COVAX Facility
por: ECCLESTON‐TURNER, MARK, et al.
Publicado: (2021)

Equitable access to COVID-19 vaccines makes a life-saving difference to all countries
por: Ye, Yang, et al.
Publicado: (2022)

An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty
por: Shiri, Mahdyeh, et al.
Publicado: (2022)

Four actions Australia should take to advance equitable global access to COVID‐19 vaccines
por: Gleeson, Deborah, et al.
Publicado: (2022)

The Stark law, from inception to COVID-19 blanket waivers: a review
por: Shenoy, Amrita, et al.
Publicado: (2022)

Bibliometric analysis of COVID‐19 publications shows the importance of telemedicine and equitable access to the internet during the pandemic and beyond
por: Samadbeik, Mahnaz, et al.
Publicado: (2022)

Best Practices for an Equitable Covid-19 Vaccination Program
por: Beste, Lauren A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qi9qibfbr8mc728but76sgk6g2